Abstract:Background: Spontaneous bacterial peritonitis (SBP) is defined as a bacterial infection of the ascitic fluid without a surgically treatable intra-abdominal infection source. SBP is a common, severe complication in cirrhosis patients with ascites, and if left untreated, in-hospital mortality may exceed 90%. However, the incidence of SBP has been lowered to approx. 20% through early diagnosis and antibiotic therapy. Clinical awareness, prompt diagnosis, and immediate treatment are advised when caring for these patients to reduce mortality and morbidity. Aim: To discuss important issues comprising types of SBP, pathogenesis, bacteriology, including the emergence of multidrug-resistant (MDR) microorganisms, prompt diagnosis, risk factors, prognosis, treatment strategies, as well as recurrence prevention through antibiotic prophylaxis until liver transplantation and future trends in treating and preventing SBP in detail. Methods: This article is a literature review and appraisal of guidelines, randomized controlled trials, meta-analyses, and other review articles found on PubMed from between 1977 and 2022. Results: There are three types of SBP. Bacterial translocation from GI tract is the most common source of SBP. Therefore, two thirds of SBP cases were caused by Gram-negative bacilli, of which Escherichia coli is the most frequently isolated pathogen. However, a trend of Gram-positive cocci associated SBP has been demonstrated in recent years, possibly related to more invasive procedures and long-term quinolone prophylaxis. A diagnostic paracentesis should be performed in all patients with cirrhosis and ascites who require emergency room care or hospitalization, who demonstrate or report consistent signs/symptoms in order to confirm evidence of SBP. Distinguishing SBP from secondary bacterial peritonitis is essential because the conditions require different therapeutic strategies. The standard treatment for SBP is prompt broad-spectrum antibiotic administration and should be tailored according to community-acquired SBP, healthcare-associated or nosocomial SBP infections and local resistance profile. Albumin supplementation, especially in patients with renal impairment, is also beneficial. Selective intestinal decontamination is associated with a reduced risk of bacterial infection and mortality in high-risk group. Conclusions: The standard treatment for SBP is prompt broad-spectrum antibiotic administration and should be tailored according to community-acquired SBP, healthcare-associated or nosocomial SBP infections and local resistance profile. Since the one-year overall mortality rates for SBP range from 53.9 to 78%, liver transplantation should be seriously considered for SBP survivors who are good candidates for transplantation. Further development of non-antibiotic strategies based on pathogenic mechanisms are also urgently needed.

Intraabdominal Urokinase for the Treatment of Secondary Bacterial Peritonitis in Cirrhosis

Nursing Experience of 61 Patients with Hepatic Cirrhosis Treated by Transfusion of Ultrafiltrated and Concentrated Self-Ascites

Spontaneous bacterial peritonitis in patients with cirrhosis: incidence, outcomes, and treatment strategies

Management of Peritonitis in the Critically Ill Patient

Study of Ascitic-Concentrated Bacteria-Filtered Intravenous Re-Transfusion (ABR) to Treat Patients with Peritonitis of Schistosoma Cirrhosis

Manual Intrapleural Saline Flushing Plus Urokinase: A Potentially Useful Therapy for Complicated Parapneumonic Effusions and Empyemas

Surgical Treatment of Persistent Pseudomonas aeruginosa Bacteraemia After n-Butyl-2-cyanoacrylate for Gastric Bleeding Varices

Double Ascites Ultrafiltration and Reinfusion into Abdominal Cavity of Hepatocirrhosis Patients with Refractory Ascites Combined with Spontaneous Bacterial Peritonitis

Spontaneous Bacterial Peritonitis in Decompensated Liver Cirrhosis—A Literature Review

Anesthetic support in synchronous liver and kidney transplantation

S4298 Complications Associated With Intraperitoneal Fibrinolytic Therapy in Decompensated Cirrhosis Complicated by Infected Loculated Ascites

[Meropenem in the treatment of surgical intra-abdominal infections]

A study of loculated tuberculous pleural effusions treated with intrapleural urokinase

CURRENT STRATEGIES IN TREATING AND PREVENTING SPONTANEOUS BACTERIAL PERITONITIS IN ADULTS

Septic shock after liver transplantation successfully treated with endotoxin and cytokine adsorption continuous renal replacement therapy: a case report and literature review

P-13 IMPACT OF SPONTANEOUS BACTERIAL PERITONITIS ON THE OUTCOME OF PATIENTS WITH HEPATIC CIRRHOSIS

Infections complicating cirrhosis

Spontaneous bacterial peritonitis—diagnosis, treatment and prevention

Update Review Article: Spontaneous Bacterial Peritonitis

Liver Resection for Primary Intrahepatic Stones: Focus on Postoperative Infectious Complications

Differentiation of Spontaneous Bacterial Peritonitis from Secondary Peritonitis in Patients with Liver Cirrhosis: Retrospective Multicentre Study